(Q37433786)

20 August 2017

1 reference

title

Endocrine and liver interaction: the role of endocrine pathways in NASH. (English)

1 reference

20 August 2017

Lucia Carulli

2

0 references

Amedeo Lonardo

object named as

Amedeo Lonardo

series ordinal

4

0 references

Marco Bertolotti

object named as

Marco Bertolotti

series ordinal

3

0 references

Paola Loria

series ordinal

1

object named as

Paola Loria

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 April 2009

1 reference

Nature Reviews Gastroenterology & Hepatology

20 August 2017

published in

1 reference

20 August 2017

volume

6

1 reference

20 August 2017

issue

4

1 reference

20 August 2017

page(s)

236-247

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2009.33

20 August 2017

exact match

0 references

cites work

Methimazole-induced hepatotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Association between thyroid function and gallstone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Association between serum TSH, free T4 and serum liver enzyme activities in a large cohort of unselected outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Expression of growth hormone receptor and its mRNA in hepatic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Protective effects of recombinant human growth hormone on cirrhotic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Beneficial effects of continuous subcutaneous insulin infusion in older patients with long-standing type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Polycystic ovary syndrome and severe nonalcoholic steatohepatitis: beneficial effect of modest weight loss and exercise on liver biopsy findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Clinical hepatology: profile of an urban, hospital-based practice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Should nonalcoholic fatty liver disease be renamed?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Thyroid disease and lipids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Peripheral metabolism of thyroid hormone and glucose homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Thyroid hormone effects on mitochondrial energetics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Cross-talk between thyroid hormone receptor and liver X receptor regulatory pathways is revealed in a thyroid hormone resistance mouse model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Bile acids and the membrane bile acid receptor TGR5--connecting nutrition and metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Mouse sterol response element binding protein-1c gene expression is negatively regulated by thyroid hormone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

The relationship between the thyroid gland and the liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Effect of hyperthyroidism and propylthiouracil treatment on liver biochemical tests

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Two cases of thyroid storm-associated cholestatic jaundice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Intrahepatic cholestasis in subclinical and overt hyperthyroidism: two case reports

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Severe hyperthyroidism induces mitochondria-mediated apoptosis in rat liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Review article: effect of bile salt pool composition on hepatic and biliary functions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Thyroid hormone-induced oxidative stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

"Let there be bile"--understanding hepatic injury in cholestasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Liver changes in patients with hyperthyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Liver transplantation for acute liver failure from drug induced liver injury in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Increased prevalence of subclinical hypothyroidism in common bile duct stone patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Hypotonia of the gall bladder, of myxedematous origin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Influence of small-bowel transit time on dietary cholesterol absorption in human beings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Bile flow to the duodenum is reduced in hypothyreosis and enhanced in hyperthyreosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Dramatically increased intestinal absorption of cholesterol following hypophysectomy is normalized by thyroid hormone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Association between hypothyroidism and small intestinal bacterial overgrowth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Prevalence of subclinical hypothyroidism in patients with metabolic syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Is Hypothyroidism a Risk Factor for Non-Alcoholic Steatohepatitis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Hypothyroidism: a possible risk factor for liver cancer in patients with no known underlying cause of liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Induced hypothyroidism accelerates the regression of liver fibrosis in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Methimazole alleviates hepatic encephalopathy in bile-duct ligated cirrhotic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

The effects of hypothyroidism on liver status of cirrhotic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Myxedema ascites: case report and literature review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Myxedema ascites with elevated serum CA 125 concentration.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Myxedema ascites with an extremely elevated CA125 Level: a case report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Comparison of the clinical features of Japanese patients with primary biliary cirrhosis in 1999 and 2004: utilization of clinical data when patients applied to receive public financial aid.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Unusual association of Hashimoto's thyroiditis with autoimmune hepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Autoimmune regulator AIRE: evidence for genetic differences between autoimmune hepatitis and hepatitis as part of the autoimmune polyglandular syndrome type 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

A case of polyglandular autoimmune syndrome type III complicated with autoimmune hepatitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Thyroid disorders in chronic hepatitis C virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Interferon Alpha Treatment and Thyroid Dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Hypothyroid myopathy as a complication of interferon alpha therapy for chronic hepatitis C virus infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Hashimoto encephalopathy with pegylated interferon alfa-2b and ribavirin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Hypothyroidism in patients with hepatocellular carcinoma treated by transarterial chemoembolization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Development of overt autoimmune hyperthyroidism in a patient therapeutically immunosuppressed after liver transplantation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Thyroid function and anti-thyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Diagnosis and Treatment of Hepatocellular Carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Mechanism of the development of obesity in animals with hypothalamic lesions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Evidence for distinct effects of GH and IGF-I in the metabolic syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

GH effect on enzyme activity of 11betaHSD in abdominal obesity is dependent on treatment duration.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Role of STAT5a in regulation of sex-specific gene expression in female but not male mouse liver revealed by microarray analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Effect of growth hormone on fatty liver in panhypopituitarism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Growth Hormone Reverses Nonalcoholic Steatohepatitis in a Patient With Adult Growth Hormone Deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Growth hormone plasma levels in nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Non-alcoholic steatohepatitis and hepatic steatosis in patients with adult onset growth hormone deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Growth hormone reduces the severity of fibrosis associated with chronic intestinal inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Hypertransaminasaemia and Addison's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Subclinical Addison's disease: a cause of persistent abnormalities in transaminase values

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Unexplained hypertransaminasaemia: clue to diagnosis of Addison's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Apoptosis in the pathogenesis and treatment of disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

The clinical importance of adrenal insufficiency in acute hepatic dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

The hepatoadrenal syndrome: a common yet unrecognized clinical condition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Adrenal insufficiency: the link between low apolipoprotein A-I levels and poor outcome in the critically ill?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Involvement of high density lipoprotein as substrate cholesterol for steroidogenesis by bovine adrenal fasciculo-reticularis cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Liver-selective glucocorticoid antagonists: a novel treatment for type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Beyond adrenal and ovarian androgen generation: Increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Polycystic ovary syndrome: diagnosis and treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Need for liver evaluation in polycystic ovary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Abnormal aminotransferase activity in women with polycystic ovary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Nonalcoholic fatty liver disease in women with polycystic ovary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Hepatocellular adenoma and polycystic ovary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Effects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome--a reappraisal

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.33

Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells

31 March 2020

1 reference

12 December 2020

Growth hormone and the metabolic syndrome.

1 reference

12 December 2020

Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome?

1 reference

12 December 2020

Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation.

1 reference

12 December 2020

Thyroid dysfunction (TD) among chronic hepatitis C patients with mild and severe hepatic fibrosis.

1 reference

12 December 2020

The prevalence of autoimmune hepatitis in Hashimoto's thyroiditis in a Turkish population

1 reference

12 December 2020

Addison's disease - a review of some clinical, pathological and immunological features.

1 reference

12 December 2020

Liver involvement and abnormal iron variables in undiagnosed Addison's disease

1 reference

12 December 2020

Metabolic effects of growth hormone therapy in an Alström syndrome patient

1 reference

12 December 2020

Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background.

1 reference

12 December 2020

Liver involvement in Addison's disease

1 reference

12 December 2020

Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis

1 reference

12 December 2020

Adrenal insufficiency in liver disease - what is the evidence?

1 reference

12 December 2020

Thyroid gland dysfunctions during antiviral therapy of chronic hepatitis C.

1 reference

12 December 2020

Adult cirrhosis due to untreated congenital hypopituitarism.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRGASTRO.2009.33

1 reference

Dimensions Publication ID

20 August 2017

1002219817

0 references

Fatcat ID

release_yqrehldunzhzfi2sb7bifxhsvu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yqrehldunzhzfi2sb7bifxhsvu

24 November 2022

mapped directly with Wikidata item

1 reference